Morphine for Dyspnea in Pulmonary Fibrosis
NCT04497831 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-08-04
Summary
"Determination of the effectiveness of nebulized morphine in the treatment of dyspnea in patients with advanced idiopathic pulmonary fibrosis"
Conditions
- Idiopathic Pulmonary Fibrosis (IPF)
Interventions
- DRUG
-
Morphine hydrochloride
5 mg milligram(s) per day per two days of dosage
- DRUG
-
Inhalation use
Sponsors & Collaborators
-
Medical University of Gdansk
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-21
- Primary Completion
- 2022-09-21
- Completion
- 2022-09-21
More Related Trials
-
Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02827721 ·Status: UNKNOWN
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Evaluation of the Multidimensional Dyspnea Profile (MDP)
NCT04090671 ·Status: UNKNOWN ·Phase: NA
-
Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
NCT05310669 ·Status: RECRUITING
-
Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis
NCT06714188 ·Status: COMPLETED
-
Disease-syndrome Characteristics of IPF
NCT07178392 ·Status: NOT_YET_RECRUITING
-
Oxidative Stress Markers in COPD
NCT04748887 ·Status: COMPLETED
-
Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-Acquired Pneumonia
NCT03473119 ·Status: UNKNOWN
-
Functional and Structural Lung Imaging in Chronic Obstructive Pulmonary Disease
NCT04966221 ·Status: UNKNOWN
-
Thorax MRI for Evaluation of Lung Morphology, Ventilation and Perfusion
NCT04719078 ·Status: UNKNOWN ·Phase: NA
-
Dyspnea in Patients With Pulmonary Fibrosis
NCT00611182 ·Status: COMPLETED
-
Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD
NCT03287921 ·Status: COMPLETED
-
Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis
NCT03104322 ·Status: COMPLETED ·Phase: NA
-
Exploring Breathing Patterns
NCT04754490 ·Status: SUSPENDED
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
Functional MR Lung Imaging Using Hyperpolarised 129Xe
NCT02976935 ·Status: COMPLETED
-
Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis
NCT06668051 ·Status: NOT_YET_RECRUITING
-
Pulmonary Fibrosis Lung Sounds Study
NCT05771740 ·Status: UNKNOWN
-
Evaluation of Novel Lung Function Parameters in Patients With Bronchial Asthma
NCT03820427 ·Status: COMPLETED
-
Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib
NCT03710824 ·Status: COMPLETED
-
Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease
NCT05957198 ·Status: COMPLETED
-
Biomarkers in Dyspnea
NCT03056547 ·Status: COMPLETED ·Phase: NA
-
Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
NCT06518473 ·Status: RECRUITING
-
Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study
NCT05313672 ·Status: ACTIVE_NOT_RECRUITING